Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Pioglitazone and tretinoin
(D00094)		[2] Pioglitazone,
Tretinoin		[3] Tretinoin (D00094),
Pioglitazone hydrochloride ,
Pioglitazone 💬 		[4] NR1C3,
PML,
RARA,
RARB 💬 		[22] AMPK signaling pathway, Acute myeloid leukemia, Efferocytosis, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[1] 2 💬
2Tretinoin
(D00094)		[1] Tretinoin[1] Tretinoin (D00094) 💬 [3] PML,
RARA,
RARB 💬 		[12] Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[3] 62, 63, 75 💬
3Tretinoin and pioglitazone HCL
(D00094)		[2] Pioglitazone,
Tretinoin		[3] Tretinoin (D00094),
Pioglitazone hydrochloride ,
Pioglitazone 💬 		[4] NR1C3,
PML,
RARA,
RARB 💬 		[22] AMPK signaling pathway, Acute myeloid leukemia, Efferocytosis, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬[1] 2 💬